AVXL
NASDAQStockAnavex Life Sciences Corp.
$4.66+0.01 (+0.22%)
52-Week Range
$3.08
$13.41
Key Stats
Market Cap
431.9M
P/E Ratio
—
Dividend Yield
—
Beta
1.05
Volume
819.9K
Avg Volume
1.1M
Performance
1M
+18.62%
3M
+12.32%
6M
-48.82%
YTD
+26.36%
1Y
-50.69%
3Y
-50.32%
5Y
-68.62%
Price Chart
ETF Exposure
AVXL is held by 63 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
| XEQT.TO | iShares Core Equity ETF Portfolio | 0.00% |
| XUU.TO | iShares Core S&P U.S. Total Market Index ETF | 0.00% |
PreviousPage 2 of 2
About AVXL ETF Exposure
Anavex Life Sciences Corp. (AVXL) is held by 63 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 431.9M, AVXL is a widely held institutional stock. The stock currently trades at $4.66. Investors can gain exposure to AVXL through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold AVXL, sorted by portfolio weight.